4-176096572-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The ENST00000280190.8(WDR17):​c.53A>G​(p.Glu18Gly) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

WDR17
ENST00000280190.8 missense

Scores

1
8
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.07
Variant links:
Genes affected
WDR17 (HGNC:16661): (WD repeat domain 17) This gene encodes a WD repeat-containing protein. It is abundantly expressed in retina and testis, and is thought to be a candidate gene for retinal disease. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
WDR17NM_181265.4 linkuse as main transcriptc.-6-15003A>G intron_variant ENST00000508596.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
WDR17ENST00000508596.6 linkuse as main transcriptc.-6-15003A>G intron_variant 1 NM_181265.4 P1Q8IZU2-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
29
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 25, 2023The c.53A>G (p.E18G) alteration is located in exon 2 (coding exon 1) of the WDR17 gene. This alteration results from a A to G substitution at nucleotide position 53, causing the glutamic acid (E) at amino acid position 18 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Uncertain
0.13
D
BayesDel_noAF
Uncertain
-0.060
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.021
T;.
Eigen
Uncertain
0.42
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.75
T;T
M_CAP
Benign
0.054
D
MetaRNN
Uncertain
0.72
D;D
MetaSVM
Benign
-0.71
T
MutationAssessor
Benign
0.69
N;.
MutationTaster
Benign
0.58
D;D;D;D
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-0.30
N;N
REVEL
Benign
0.24
Sift
Uncertain
0.019
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
D;.
Vest4
0.67
MutPred
0.46
Gain of sheet (P = 0.0049);Gain of sheet (P = 0.0049);
MVP
0.82
MPC
0.55
ClinPred
0.95
D
GERP RS
5.5
Varity_R
0.14
gMVP
0.51

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr4-177017723; API